Related Experiment Videos
Diabetes and advanced glycation endproducts
1Department of Geriatrics, Mount Sinai School of Medicine, NY 10029, USA. helen.vlassara@mssm.edu
Journal of Internal Medicine
|March 22, 2002
Summary
Advanced glycation endproducts (AGE) damage molecules and increase oxidative stress, contributing to aging and diabetic complications. Research is exploring ways to prevent AGE formation, reduce toxicity, and aid removal.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Advanced glycation endproducts (AGE) are bioactive molecules that modify biological structures.
- AGE accumulation is linked to oxidative stress and implicated in diabetic complications and aging.
Purpose of the Study:
- To review the role of AGE in molecular damage and disease.
- To discuss mechanisms of AGE involvement and clearance.
- To highlight therapeutic strategies targeting AGE.
Main Methods:
- Literature review of AGE formation, effects, and clearance pathways.
- Analysis of AGE involvement in diabetic complications and aging.
- Evaluation of current and potential pharmacological interventions.
Main Results:
- AGE alter molecular structure and function, increasing oxidative stress.
- AGE contribute to atherosclerosis, renal, eye, and neurological diseases.
- Renal clearance is crucial for AGE disposal.
Conclusions:
- AGE play a significant role in disease pathogenesis and aging.
- Targeting AGE formation, toxicity, or inactivation presents therapeutic opportunities.
- Pharmacological strategies are under investigation for AGE-related conditions.